Adventitial delivery of platelet-derived endothelial cell growth factor gene prevented intimal hyperplasia of vein graft

Journal of Vascular Surgery

Volumn 48, Issue 6, 2008, Pages 1566-1574

  Handa, Mitsuteru ^a   Li, Wei ^a   Morioka, Kouichi ^a   Takamori, Atsushi ^a   Yamada, Narihisa ^a   Ihaya, Akio ^a  

^a Faculty of Medical Sciences   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; HEME OXYGENASE 1; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; POLOXAMER; SODIUM CHLORIDE; THYMIDINE PHOSPHORYLASE; TRYPSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; CAROTID ARTERY; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG EFFECT; DRUG INHIBITION; FEMALE; GENE EXPRESSION; GENE TRANSFER; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; TRANSGENE; VASCULAR SMOOTH MUSCLE; VEIN GRAFT;

ANIMALS; CONNECTIVE TISSUE; DISEASE MODELS, ANIMAL; DNA; FEMALE; GENE EXPRESSION; GENE THERAPY; GRAFT OCCLUSION, VASCULAR; HYPERPLASIA; IMMUNOBLOTTING; JUGULAR VEINS; MUSCLE, SMOOTH, VASCULAR; RABBITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYMIDINE PHOSPHORYLASE; TREATMENT OUTCOME;

EID: 57949107721     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2008.07.029     Document Type: Article

References (36)

1. Motwani J.G., and Topol E.J. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 97 (1998) 916-931
2. Davies M.G., and Hagen P.O. Pathobiology of intimal hyperplasia. Br J Surg 81 (1994) 1254-1269
3. O'Blenes S.B., Zaidi S.H., Cheah A.Y., McIntyre B., Kaneda Y., and Rabinovitch M. Gene transfer of the serine elastase inhibitor elafin protects against vein graft degeneration. Circulation 102 (2000) III289-III295
4. Jiang Z., Berceli S.A., Pfahnl C.L., Wu L., Goldman D., Tao M., et al. Wall shear modulation of cytokines in early vein grafts. J Vasc Surg 40 (2004) 345-350
5. Yamashita A., Hanna A.K., Hirata S., Dardik A., and Sumpio B.E. Antisense basic fibroblast growth factor alters the time course of mitogen-activated protein kinase in arterialized vein graft remodeling. J Vasc Surg 37 (2003) 866-873
6. Mann M.J., Whittemore A.D., Donaldson M.C., Belkin M., Conte M.S., Polak J.F., et al. Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial. Lancet 354 (1999) 1493-1498
7. Grube E., and Fitzgerald P. Phase II trial of the E2F decoy in coronary bypass grafting (2001) Presented at the Scientific Sessions of the American Heart Association Annual Meeting, Anaheim, CA; Nov 11-14
8. Alexander J.H., Hafley G., Harrington R.A., Peterson E.D., Ferguson Jr. T.B., Lorenz T.J., et al. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA 294 (2005) 2446-2454
9. Conte M.S., Bandyk D.F., Clowes A.W., Moneta G.L., Seely L., Lorenz T.J., et al. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg 43 (2006) 742-751 discussion 751
10. Barton G.J., Ponting C.P., Spraggon G., Finnis C., and Sleep D. Human platelet-derived endothelial cell growth factor is homologous to Escherichia coli thymidine phosphorylase. Protein Sci 1 (1992) 688-690
11. Toi M., Atiqur Rahman M., Bando H., and Chow L.W. Thymidine phosphorylase (platelet-derived endothelial-cell growth factor) in cancer biology and treatment. Lancet Oncol 6 (2005) 158-166
12. Ishikawa F., Miyazono K., Hellman U., Drexler H., Wernstedt C., Hagiwara K., et al. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 338 (1989) 557-562
13. Haraguchi M., Miyadera K., Uemura K., Sumizawa T., Furukawa T., Yamada K., et al. Angiogenic activity of enzymes. Nature 368 (1994) 198
14. Ikeda R., Furukawa T., Kitazono M., Ishitsuka K., Okumura H., Tani A., et al. Molecular basis for the inhibition of hypoxia-induced apoptosis by 2-deoxy-D-ribose. Biochem Biophys Res Commun 291 (2002) 806-812
15. Li W., Tanaka K., Morioka K., Uesaka T., Yamada N., Takamori A., et al. Thymidine phosphorylase gene transfer inhibits vascular smooth muscle cell proliferation by upregulating heme oxygenase-1 and p27KIP1. Arterioscler Thromb Vasc Biol 25 (2005) 1370-1375
16. Zou Y., Dietrich H., Hu Y., Metzler B., Wick G., and Xu Q. Mouse model of venous bypass graft arteriosclerosis. Am J Pathol 153 (1998) 1301-1310
17. Furuyama T., Komori K., Shimokawa H., Matsumoto Y., Uwatoku T., Hirano K., et al. Long-term inhibition of Rho kinase suppresses intimal thickening in autologous vein grafts in rabbits. J Vasc Surg 43 (2006) 1249-1256
18. Igyarto B.Z., Magyar A., and Olah I. Origin of follicular dendritic cell in the chicken spleen. Cell Tissue Res 327 (2007) 83-92
19. West N.E., Qian H., Guzik T.J., Black E., Cai S., George S.E., and Channon K.M. Nitric oxide synthase (nNOS) gene transfer modifies venous bypass graft remodeling: effects on vascular smooth muscle cell differentiation and superoxide production. Circulation 104 (2001) 1526-1532
20. George S.J., Lloyd C.T., Angelini G.D., Newby A.C., and Baker A.H. Inhibition of late vein graft neointima formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3. Circulation 101 (2000) 296-304
21. Lehrman S. Virus treatment questioned after gene therapy death. Nature 401 (1999) 517-518
22. Tripathy S.K., Black H.B., Goldwasser E., and Leiden J.M. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat Med 2 (1996) 545-550
23. Escobar-Chavez J.J., Lopez-Cervantes M., Naik A., Kalia Y.N., Quintanar-Guerrero D., and Ganem-Quintanar A. Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations. J Pharm Pharm Sci 9 (2006) 339-358
24. Lemieux P., Guerin N., Paradis G., Proulx R., Chistyakova L., Kabanov A., and Alakhov V. A combination of poloxamers increases gene expression of plasmid DNA in skeletal muscle. Gene Ther 7 (2000) 986-991
25. Kikuchi K., McDonald A.D., Sasano T., and Donahue J.K. Targeted modification of atrial electrophysiology by homogeneous transmural atrial gene transfer. Circulation 111 (2005) 264-270
26. Wan L., Li D., and Wu Q. Perivenous application of fibrin glue as external support enhanced adventitial adenovirus transfection in rabbit model. J Surg Res 135 (2006) 312-316
27. Li W., Tanaka K., Ihaya A., Fujibayashi Y., Takamatsu S., Morioka K., et al. Gene therapy for chronic myocardial ischemia using platelet-derived endothelial cell growth factor in dogs. Am J Physiol Heart Circ Physiol 288 (2005) H408-H415
28. Li W., Tanaka K., Morioka K., Takamori A., Handa M., Yamada N., et al. Long-term effect of gene therapy for chronic ischemic myocardium using platelet-derived endothelial cell growth factor in dogs. J Gene Med 10 (2008) 412-420
29. Yamada N., Li W., Ihaya A., Kimura T., Morioka K., Uesaka T., et al. Platelet-derived endothelial cell growth factor gene therapy for limb ischemia. J Vasc Surg 44 (2006) 1322-1328
30. Somjen D., Jaffe A., Knoll E., Kohen F., Amir-Zaltsman Y., and Stern N. Platelet-derived endothelial cell growth factor inhibits DNA synthesis in vascular smooth muscle cells. Am J Hypertens 12 (1999) 882-889
31. Ehsan A., Mann M.J., Dell'Acqua G., Tamura K., Braun-Dullaeus R., and Dzau V.J. Endothelial healing in vein grafts: proliferative burst unimpaired by genetic therapy of neointimal disease. Circulation 105 (2002) 1686-1692
32. Torsney E., Mayr U., Zou Y., Thompson W.D., Hu Y., and Xu Q. Thrombosis and neointima formation in vein grafts are inhibited by locally applied aspirin through endothelial protection. Circ Res 94 (2004) 1466-1473
33. Sengupta S., Sellers L.A., Matheson H.B., and Fan T.P. Thymidine phosphorylase induces angiogenesis in vivo and in vitro: an evaluation of possible mechanisms. Br J Pharmacol 139 (2003) 219-231
34. Deramaudt B.M., Braunstein S., Remy P., and Abraham N.G. Gene transfer of human heme oxygenase into coronary endothelial cells potentially promotes angiogenesis. J Cell Biochem 68 (1998) 121-127
35. Brouard S., Otterbein L.E., Anrather J., Tobiasch E., Bach F.H., Choi A.M., et al. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med 192 (2000) 1015-1026
36. Khurana R., Zhuang Z., Bhardwaj S., Murakami M., De Muinck E., Yla-Herttuala S., et al. Angiogenesis-dependent and independent phases of intimal hyperplasia. Circulation 110 (2004) 2436-2443